Total Credits: 1.0 including 1.0 AOA Category 1-A Credit(s)
First presented at the 2025 Ohio Osteopathic Symposium, the OOA is proud to offer this on-demand CME Program presented by Susan Ratay, DO.
1. Summarize supporting evidence for using continuous glucose monitoring systems (CGMs) in individuals with Type 1 and Type 2 diabetes.
2. Review absolute and relative risks when prescribing GLP-1 RA and GIP.
3. Discuss the role for adjunct use of weight loss medications in conbination with surgery.
The Ohio Osteopathic Foundation (OOF) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The OOF designates this activity for a maximum of 22.50 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
AMA PRA Category 1 Credit™ This activity has been approved for AMA PRA Category 1 Credits™. The American Osteopathic Association designates this blended activity for a maximum of 20.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The 2025 Ohio Osteopathic Symposium is designed to comply with Uniform Guidelines for Accrediting Agencies of Continuing Medical Education. Questions or complaints concerning the program should be submitted in writing and directed to the Executive Director.
All grievances will receive an initial written response within 30 days of receipt. Additional information concerning compliance may be obtained by contacting the Bureau of Osteopathic Education of the AOA at: 142 E. Ontario St., Chicago, IL 60611-2864.
1)AstraZeneca - consulting, speakers bureau
2) NovoNordisk - consulting, speakers bureau
3) Weight Management Partners - consulting
Dr. Susan Ratay graduated from Lake Erie College of Osteopathic Medicine in 2012. She completed training in family medicine, integrative medicine, and obesity medicine.
Dr Ratay is board certified in obesity medicine, and has had a primary care practice in the area for 10 years. She has experience with the use of obesity medications as an additional treatment to weight management.